BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30113762)

  • 21. The impact of head and neck radiotherapy on salivary flow and quality of life: Results of the ORARAD study.
    Lin A; Helgeson ES; Treister NS; Schmidt BL; Patton LL; Elting LS; Lalla RV; Brennan MT; Sollecito TP
    Oral Oncol; 2022 Apr; 127():105783. PubMed ID: 35231809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of radiotherapy on the quality of life in patients with early-stage clinical head and neck cancer.
    Milecki J; Żmijewska-Tomczak M; Osmola K; Wierzbicka M
    Otolaryngol Pol; 2021 May; 75(5):1-8. PubMed ID: 34552020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors.
    Beetz I; Schilstra C; Burlage FR; Koken PW; Doornaert P; Bijl HP; Chouvalova O; Leemans CR; de Bock GH; Christianen ME; van der Laan BF; Vissink A; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):86-93. PubMed ID: 21632133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
    Graff P; Lapeyre M; Desandes E; Ortholan C; Bensadoun RJ; Alfonsi M; Maingon P; Giraud P; Bourhis J; Marchesi V; Mège A; Peiffert D
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1309-17. PubMed ID: 17289292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study.
    Tribius S; Raguse M; Voigt C; Münscher A; Gröbe A; Petersen C; Krüll A; Bergelt C; Singer S
    Strahlenther Onkol; 2015 Jun; 191(6):501-10. PubMed ID: 25747264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life after different treatment modalities for carcinoma of the oropharynx.
    Tschudi D; Stoeckli S; Schmid S
    Laryngoscope; 2003 Nov; 113(11):1949-54. PubMed ID: 14603054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation.
    Fang FM; Tsai WL; Chien CY; Chiu HC; Wang CJ; Chen HC; Hsiung CY
    Oncology; 2005; 68(4-6):405-13. PubMed ID: 16020970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Explorative study on mucosal and major salivary secretion rates, caries and plaque microflora in head and neck cancer patients.
    Almståhl A; Finizia C; Carlén A; Fagerberg-Mohlin B; Alstad T
    Int J Dent Hyg; 2018 Nov; 16(4):450-458. PubMed ID: 29532594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume.
    Huguenin PU; Taussky D; Moe K; Meister A; Baumert B; Lütolf UM; Glanzmann C
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):47-52. PubMed ID: 10477005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiation therapy.
    Memtsa PT; Tolia M; Tzitzikas I; Bizakis J; Pistevou-Gombaki K; Charalambidou M; Iliopoulou C; Kyrgias G
    Mol Clin Oncol; 2017 May; 6(5):789-793. PubMed ID: 28529753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer.
    Teguh DN; Levendag PC; Noever I; Voet P; van der Est H; van Rooij P; Dumans AG; de Boer MF; van der Huls MP; Sterk W; Schmitz PI
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):711-6. PubMed ID: 19386439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral health-related quality of life after radiation therapy for head and neck cancer: the OraRad study.
    Patton LL; Helgeson ES; Brennan MT; Treister NS; Sollecito TP; Schmidt BL; Lin A; Chera BS; Lalla RV
    Support Care Cancer; 2023 Apr; 31(5):286. PubMed ID: 37079106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MUC5B levels in submandibular gland saliva of patients treated with radiotherapy for head-and-neck cancer: a pilot study.
    Dijkema T; Terhaard CH; Roesink JM; Raaijmakers CP; van den Keijbus PA; Brand HS; Veerman EC
    Radiat Oncol; 2012 Jun; 7():91. PubMed ID: 22704532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer.
    Scott SI; Kathrine Ø Madsen A; Rubek N; Charabi BW; Wessel I; Fredslund Hadjú S; Jensen CV; Stephen S; Patterson JM; Friborg J; Hutcheson KA; Kehlet H; von Buchwald C
    Cancer Med; 2021 Jan; 10(2):483-495. PubMed ID: 33277795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The course of symptoms of anxiety and depression from time of diagnosis up to 2 years follow-up in head and neck cancer patients treated with primary (chemo)radiation.
    van Beek FE; Jansen F; Mak L; Lissenberg-Witte BI; Buter J; Vergeer MR; Voortman J; Cuijpers P; Leemans CR; Verdonck-de Leeuw IM
    Oral Oncol; 2020 Mar; 102():104576. PubMed ID: 32028135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
    Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral complications at 6 months after radiation therapy for head and neck cancer.
    Lalla RV; Treister N; Sollecito T; Schmidt B; Patton LL; Mohammadi K; Hodges JS; Brennan MT;
    Oral Dis; 2017 Nov; 23(8):1134-1143. PubMed ID: 28675770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microflora in oral ecosystems and salivary secretion rates--A 3-year follow-up after radiation therapy to the head and neck region.
    Almståhl A; Wikström M; Fagerberg-Mohlin B
    Arch Oral Biol; 2015 Sep; 60(9):1187-95. PubMed ID: 26058004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.